Clinical Trial: Hepatitis C: Grading and Staging by MR


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Hepatitis C: Grading and Staging by MR

This study is currently recruiting patients.

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

To compare MR imaging findings with biopsy for grading and staging early hepatitis C.

Condition
Hepatitis

MedlinePlus related topics: Hepatitis

Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study

Further Study Details:

Expected Total Enrollment: 80

Study start: April 2003

Eligibility

Ages Eligible for Study: 18 Years - 75 Years, Genders Eligible for Study: Both

Criteria

Referral only

Location and Contact Information

Pennsylvania
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States; Recruiting

Victor Navarro, MD Victor.Navarro@mail.tju.edu

More Information

Study ID Numbers: HCGSMR
Record last reviewed: May 2004
Record first received: April 24, 2003
ClinicalTrials.gov Identifier: NCT00059397
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services